Company: MLTX
Filing Date: 2025-05-12
Form Type: 8-K
Source: 0001821586-25-000009
Chunk: 1

Company: MoonLake Immunotherapeutics
Filing Date: 2025-05-12
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. The following exhibit is being furnished herewith:

  Exhibit Number      Exhibit Title or Description                                                 
            99.1      Press Release, dated May 12, 2025                                            
 ───────────────────────────────────────────────────────────────────────────────────────────────────
             104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  MOONLAKE IMMUNOTHERAPEUTICS                               
  By:                              /s/ Matthias Bodenstedt  
  Name:                            Matthias Bodenstedt      
  Title:                           Chief Financial Officer